SCHEMBL3598980

SCHEMBL3598980

CC(=O)OCCC1CCOC1=O

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
MAPK1 P28482 1/20 0.33
SLC18A3 Q16572 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8645517 0.89 FKBP1A (0.35) ALDH1A1KDM4EHPGDHSD17B10MTNR1A
SCHEMBL11368930 0.88 MTNR1A (0.40) ALDH1A1MTNR1AMTNR1B
SCHEMBL11369090 0.88 MTNR1A (0.40) ALDH1A1MTNR1AMTNR1B
SCHEMBL14341641 0.86 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8763009 0.84 KDM4E (0.36) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL7657725 0.83 NLRP3 (0.41) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL14341640 0.80 TSHR (0.41) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL14489286 0.79 FKBP1A (0.43) ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8600478 0.79 POLB (0.34) MAPK1
SCHEMBL9298152 0.78 PDE4D (0.35) ALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994112-B1 Method for separating contaminants from 3-(2'-acetoxy-ethyl)-dihydro-2(3h)furanone BASF AG (DE) 2002-07-24 EP claimed
EP-1037884-B1 METHOD FOR SEPARATING CONTAMINANTS FROM 3-(2'-ACETOXY-ETHYL-DIHYDRO-2(3H)FURANONE BASF AG (DE) 2002-03-13 EP claimed
US-6201135-B1 PREPARING 3-(2'-ACETOXYETHYL)DIHYDRO-2(3H)-FURANONE CONTAINING UNDESIRABLE IMPURITIES IN A MANNER KNOWN PER SE BY ACETYLATING 3-(2'-HYDROXYETHYL)-DIHYDRO-2-(3H)-FURANONE, TREATING IT WITH STRONG MINERAL ACIDS, REMOVING DECOMPOSITION PRODUCTS BASF AKTIENGESELLSCHAFT (DE) 2001-03-13 US claimed
CN-1281445-A Method for removing impurities in 3- (2' -acetoxyethyl) dihydro-2 (3H) -furanone BASF AG (DE) 2001-01-24 CN claimed
EP-0994112-A1 Method for separating contaminants from 3-(2'-acetoxy-ethyl)-dihydro-2(3h)furanone BASF AKTIENGESELLSCHAFT (DE) 2000-04-19 EP claimed
EP-0584663-B1 Process for the preparation of tetrahydropyran-4-carboxylic acid and his esters BASF AG (DE) 1998-02-25 EP claimed
US-5371246-A Preparation of tetrahydropyran-4-carboxylic acid and esters thereof BASF AKTIENGESELLSCHAFT (DE) 1994-12-06 US claimed
EP-0584663-A2 Process for the preparation of tetrahydropyran-4-carboxylic acid and his esters BASF Aktiengesellschaft (DE) 1994-03-02 EP claimed
US-20100105929-A1 PROCESS FOR THE PREPARATION OF y-BUTYROLACTONES LONZA LTD. (CH) 2010-04-29 US disclosed
EP-2079720-A1 PROCESS FOR THE PREPARATION OF GAMMA-BUTYROLACTONES LONZA AG (CH) 2009-07-22 EP disclosed
EP-1911752-A1 Process for the preparation of butyrolactones LONZA AG (CH) 2008-04-16 EP disclosed
WO-2008040530-A1 PROCESS FOR THE PREPARATION OF γ-BUTYROLACTONES LONZA AG (CH) 2008-04-10 WO disclosed
US-6488818-B1 DISTILLATION BASF AKTIENGESELLSCHAFT (DE) 2002-12-03 US disclosed
US-6488818-B1 DISTILLATION BASF AKTIENGESELLSCHAFT (DE) 2002-12-03 US disclosed
EP-0588224-A1 Process for the preparation of 3-(2'-oxyethyl)-dihydro-2-(3H)furanones BASF Aktiengesellschaft (DE) 1994-03-23 EP disclosed
EP-0584663-A2 Process for the preparation of tetrahydropyran-4-carboxylic acid and his esters BASF Aktiengesellschaft (DE) 1994-03-02 EP disclosed
EP-0584631-A1 Process of preparing 3-(2'-acyloxyethyl)-dihydro-2(3H)furanones BASF Aktiengesellschaft (DE) 1994-03-02 EP disclosed
EP-0246581-B1 PROCESS FOR THE PREPARATION OF ALPHA-SUBSTITUTED GAMMA-BUTYROLACTONES BASF Aktiengesellschaft (DE) 1991-10-09 EP disclosed
US-4831166-A REACTING ALKYLENE OXIDE WITH ACYLACETATE USING IONIC HALIDE CATALYST BASF AKTIENGESELLSCHAFT (DE) 1989-05-16 US disclosed
EP-0246581-A2 Process for the preparation of alpha-substituted gamma-butyrolactones BASF Aktiengesellschaft (DE) 1987-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105929-A1 PROCESS FOR THE PREPARATION OF y-BUTYROLACTONES CYP17A1, HSD17B7, CYP19A1 ALDH1A1 1212/4885KDM4E 219/4885HPGD 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.